Evidence map›Paper›PMID 35216450›Full record

ArticleInternational journal of molecular sciences2022

In-Vitro Catalytic and Antibacterial Potential of Green Synthesized CuO Nanoparticles against Prevalent Multiple Drug Resistant Bovine Mastitogen

Anwar Ul-Hamid, Hatim Dafalla, Abbas Saeed Hakeem, Ali Haider, Muhammad Ikram

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Biogenic copper and copper oxide nanoparticles to combat multidrug-resistantBiotechnology reports (Amsterdam, Netherlands) · 2025
    Review
  5. Article
  6. Laser Ablation for the Synthesis of Cu/CuInternational journal of molecular sciences · 2024
    Article
  7. Review
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Anwar Ul-HamidCore Research Facilities, King Fahd University of Petroleum & Minerals, Dhahran 31261, Saudi Arabia.ORCID 0000-0002-0259-301X
Hatim DafallaCore Research Facilities, King Fahd University of Petroleum & Minerals, Dhahran 31261, Saudi Arabia.
Abbas Saeed HakeemInterdisciplinary Research Center for Hydrogen and Energy Storage, King Fahd University of Petroleum & Minerals, Dhahran 31261, Saudi Arabia.ORCID 0000-0003-1422-442X
Ali HaiderFaculty of Veterinary and Animal Sciences, Muhammad Nawaz Shareef University of Agriculture (MNSUA), Multan 66000, Pakistan.
Muhammad IkramSolar Cell Applications Research Lab, Department of Physics, Government College University, Lahore 54000, Pakistan.ORCID 0000-0001-7741-789X

Funding

King Fahd University of Petroleum and Minerals DF201015
6 · The paper itself

Abstract

Nanoparticles prepared from bio-reduction agents are of keen interest to researchers around the globe due to their ability to mitigate the harmful effects of chemicals. In this regard, the present study aims to synthesize copper oxide nanoparticles (CuO NPs) by utilizing root extracts of ginger and garlic as reducing agents, followed by the characterization and evaluation of their antimicrobial properties against multiple drug resistant (MDR)

Indexed as

Metal NanoparticlesNanoparticlesZingiber officinaleAnimalsAnti-Bacterial AgentsCattleCopperMicrobial Sensitivity TestsPlant ExtractsStaphylococcus aureusAnti-Bacterial AgentsCoppercupric oxidePlant Extractsbactericidal potentialCuOdye degradationMDRnanoparticles

Identifiers

PMID35216450
PMCPMC8878101

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.